Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Long-Term Follow-up of Patients with Corticosteroid-Refractory Graft-Versus-Host Disease Treated with Ruxolitinib

Robert Zeiser, MD, Andreas Burchert, MD, Claudia Lengerke, MD, Mareike Verbeek, Kristina Maas-Bauer, MD, Stephan Metzelder, MD, Silvia Spoerl, MD, Markus Ditschkowski, MD, Matyas Ecsedi, MD, Katja Sockel, MD, Francis Ayuk, MD, Ajib Salem, MD, Flore Sicre de Fontbrune, MD, Il-Kang Na, MD, Penter Livius, MD, Udo Holtick, MD PhD, Dominik Wolf, MD, Esther Schuler, MD, Everett Meyer, MD PhD, Petya Apostolova, MD, Hartmut Bertz, MD, Reinhard Marks, MD, Michael Lübbert, MD, Ralph Wäsch, MD, Christof Scheid, MD PhD, Friedrich Stölzel, MD, Rainer Ordemann, MD, Gesine Bug, MD, Guido Kobbe, MD, Omid Shah, MD, Robert S. Negrin, MD, Mats Brune, MD PhD, Alexandros Spyridonidis, MD PhD, Annette Schmitt-Graeff, MD, Walter J.F.M. van der Velden, MD PhD, Gerwin Huls, MD PhD, Stephan Mielke, MD, Goetz Ulrich Grigoleit, MD, Jurgen Kuball, MD PhD, Ryan P Flynn, PhD, Gabriele Ihorst, PhD, Jing Du, Bruce R. Blazar, MD, Renate Arnold, MD, Nicolaus Kröger, MD, Jakob R. Passweg, Joerg Halter, MD, Gérard Socié, MD PhD, Dietrich W. Beelen, Prof. Dr. MD, Christian Peschel, MD, Andreas Neubauer, Jürgen Finke, Justus Duyster, MD, Nikolas von Bubnoff, MD

Blood (2016) 128 (22): 4561.

https://doi.org/10.1182/blood.V128.22.4561.4561

Published: 2016

Journal Articles

Peptide-Receptor Radiotherapy with CXCR4-Targeting Pentixather Reduces Leukemia Burden in Acute Leukemia PDX and Patients

Stefan Habringer, MD, Peter Herhaus, Margret Schottelius, PhD, Constantin Lapa, MD, Rouzanna Istvanffy, PhD, Katharina Götze, Katja Steiger, DVM, Binje Vick, PhD, Christian Peschel, MD, Robert Oostendorp, PhD, Irmela Jeremias, MD, Hans-Jürgen Wester, PhD, Goetz Ulrich Grigoleit, MD, Ulrich Keller, MD

Blood (2016) 128 (22): 4055.

https://doi.org/10.1182/blood.V128.22.4055.4055

Published: 2016

Journal Articles

Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients

Robert Zeiser, MD, Andreas Burchert, MD, Claudia Lengerke, MD, Mareike Verbeek, Kristina Maas-Bauer, MD, Stephan Metzelder, MD, Silvia Spoerl, MD, Markus Ditschkowski, MD, Matyas Ecsedi, MD, Katja Sockel, MD, Francis Ayuk, MD, Salem Ajib, MD, Flore Sicre de Fontbrune, MD, Il-Kang Na, MD, Livius Penter, MD, Udo Holtick, MD PhD, Dominik Wolf, MD, Esther Schuler, MD, Everett Meyer, MD PhD, Petya Apostolova, MD, Hartmut Bertz, MD, Reinhard Marks, Michael Luebbert, MD, Ralph M. Waesch, MD PhD, Christof Scheid, MD PhD, Friedrich Stölzel, MD, Rainer Ordemann, MD, Gesine Bug, MD, Guido Kobbe, MD, Robert Negrin, MD, Mats L Brune, Alexandros Spyridonidis, Annette Schmitt-Graeff, MD, Walter van der Velden, MD, Gerwin Huls, MD PhD, Stephan Mielke, MD, Goetz Ulrich Grigoleit, MD, Jurgen Kuball, MDPhD, Ryan P Flynn, PhD, Gabriele Ihorst, PhD, Jing Du, Bruce R. Blazar, MD, Renate Arnold, MD, Nicolaus Kröger, MD, Joerg Halter, MD, Gerard Socie, Dietrich Beelen, MD, Christian Peschel, MD, Andreas Neubauer, MD, Juergen Finke, MD, Justus Duyster, MD PhD, Nikolas von Bubnoff, MD

Blood (2015) 126 (23): 858.

https://doi.org/10.1182/blood.V126.23.858.858

Published: 2015

Journal Articles

Allogeneic SCT in Multiple Myeloma: Limited Predictive Value of Chimerism Analysis for Heralding Relapse/Progression Due to Extramedullary Disease

Leo Rasche, Christoph Röllig, MD, Stephan Mielke, MD, Goetz Ulrich Grigoleit, MD, Martin Schreder, MD, Sophia Danhof, MD, Martin Bornhäuser, MD, Hermann Einsele, Christian Thiede, MD, Stefan Knop

Blood (2015) 126 (23): 4396.

https://doi.org/10.1182/blood.V126.23.4396.4396

Published: 2015

Journal Articles

High-density preculture of PBMCs restores defective sensitivity of circulating CD8 T cells to virus- and tumor-derived antigens

Julia Wegner, Stephan Hackenberg, Claus-Jürgen Scholz, Sergey Chuvpilo, Dmitry Tyrsin, Alexey A. Matskevich, Götz Ulrich Grigoleit, Stefan Stevanović, Thomas Hünig

Blood (2015) 126 (2): 185–194.

https://doi.org/10.1182/blood-2015-01-622704

Published: 2015

Includes: Supplemental data

Journal Articles

Wilms Tumor Protein-1-Derived 9-Mer Peptide Induces CD4 T-Cell Responses in an HLA-DR Restricted Manner

Shigeo Fuji, Julia Fischer, Markus Kapp, Thomas G Bumm, MD, Hermann Einsele, Stefan Stevanovic, PhD, Hans-Georg Rammensee, Prof., Thomas Hunig, Götz Ulrich Grigoleit, MD

Blood (2012) 120 (21): 4351.

https://doi.org/10.1182/blood.V120.21.4351.4351

Published: 2012

Journal Articles

Salvage Therapy with Everolimus Reduces the Severity of Treatment-Refractory Chronic Graft-Versus-Host Disease without Impairing Disease Control: A Dual Center Experience

Stephan Mielke, MD, Mathias Lutz, Medical Student, Judith Schmidhuber, Medical Student, Markus Kapp, MD, Julia Ammer, MD, Hermann Einsele, MD, Götz Ulrich Grigoleit, MD, Ernst Holler, MD, Daniel Wolff, MD

Blood (2012) 120 (21): 4173.

https://doi.org/10.1182/blood.V120.21.4173.4173

Published: 2012

Journal Articles

Simultaneous Isolation and Enrichment of Multi Specific and Multi Functional T-Cells Populations for Treatment of Patients Undergoing Allogeneic Hematopoetic Stem Cell Transplantation,

Meike Kruse, Halvard Bonig, MD, MA, Markus Kapp, Lothar Germeroth, Hermann Einsele, MD, Götz Ulrich Grigoleit

Blood (2011) 118 (21): 4056.

https://doi.org/10.1182/blood.V118.21.4056.4056

Published: 2011

Journal Articles

Monocyte-Derived Dendritic Cells Pulsed with Aspergillus Fumigatus Components Enhance the Anti-Aspergillus Effect of Human Natural Killer Cells

Maria Bouzani, Anna Lena Schmitt, Vishu Aimanianda, Christin Flechsig, Sen Mui Tan, Götzi Ulrich Grigoleit, Jean Paul Latge, Hermann Einsele, MD, Juergen Loeffler

Blood (2011) 118 (21): 2983.

https://doi.org/10.1182/blood.V118.21.2983.2983

Published: 2011

Journal Articles

Modified Vaccinia Ankara Virus (MVA) Induces a Th1-Polarized Immune Response in Antigen-Presenting Cells (APCs).

Christin Flechsig, Yasemin Suezer, DVM, Markus Kapp, MD, Gerd Sutter, DVM, Hermann Einsele, MD, Götz Ulrich Grigoleit, MD

Blood (2009) 114 (22): 4650.

https://doi.org/10.1182/blood.V114.22.4650.4650

Published: 2009

Journal Articles

Combined Phosphoepitope Specific Flow Cytometry and MHC-Multimer Staining - A New Tool to Monitor Antigen-Specific Signaling in CMV-Specific T-Cells.

Markus Kapp, MD, Rainer Thiele, PhD, Elke Baumeister, Kerstin Fick, Gernot Stuhler, MD, Andreas Opitz, MD, Hermann Einsele, MD, Götz Ulrich Grigoleit, MD

Blood (2009) 114 (22): 4737.

https://doi.org/10.1182/blood.V114.22.4737.4737

Published: 2009

Journal Articles

Evaluation of Different Co-Stimulatory Signals in the Priming and Expansion of HLA-B*0702/CMV_pp65 Restricted CTLs after Stimulation with aAPC

Markus Kapp, Kerstin Fick, Stefanie Jackob, Rainer Thiele, Mathias Oelke, Harald Wajant, Jonathan P. Schneck, Andreas Opitz, Hermann Einsele, G.ötz Ulrich Grigoleit

Blood (2008) 112 (11): 4902.

https://doi.org/10.1182/blood.V112.11.4902.4902

Published: 2008

Journal Articles

CTL Responses Against Tumor Associated Antigens Are Part of the Graft Versus Leukemia-Effect and Protect from Relapse after Allogeneic Hematopoetic Stem Cell Transplantation.

Markus Kapp, Stefan Stevanovic, Kerstin Fick, Juergen Loeffler, Sen Mui Tan, Andreas Opitz, Torsten Tonn, Hermann Einsele, Goetz Ulrich Grigoleit

Blood (2007) 110 (11): 3231.

https://doi.org/10.1182/blood.V110.11.3231.3231

Published: 2007

Journal Articles

Streptamer Technology for the Assessment of CMVpp65 Specific CD8+ T Cell Frequencies and for the Adoptive T Cell Transfer to Post-Transplant Patients.

Anita Schmitt, MD, Junxia Yao, MD, Hermann Einsele, PhD, MD, Ulrich Grigoleit, MD, Dirk Busch, PhD, MD, Manuel Odendahl, MD, Lothar Germeroth, PhD, Torsten Tonn, PhD, MD, Markus Wiesneth, MD, Markus Rojewski, MD, Clemens Bechter, Stefanie von Harsdorf, MD, Hartmut Dohner, PhD, MD, Donald Bunjes, PhD, MD, Michael Schmitt, PhD, MD

Blood (2007) 110 (11): 1964.

https://doi.org/10.1182/blood.V110.11.1964.1964

Published: 2007

Journal Articles

Dendritic Cell Vaccination Induces HCMV Specific T-Cell Responses in Allogeneic Stem Cell Recipients.

Ulrich Grigoleit, Markus Kapp, Holger Hebart, Robert Beck, Gerhard Jahn, Hermann Einsele

Blood (2005) 106 (11): 475.

https://doi.org/10.1182/blood.V106.11.475.475

Published: 2005

Journal Articles

Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

Hermann Einsele, Eddy Roosnek, Nathalie Rufer, Christian Sinzger, Susanne Riegler, Jürgen Löffler, Ulrich Grigoleit, Arnaud Moris, Hans-Georg Rammensee, Lothar Kanz, Annette Kleihauer, Friederike Frank, Gerhard Jahn, Holger Hebart

Blood (2002) 99 (11): 3916–3922.

https://doi.org/10.1182/blood.V99.11.3916

Published: 2002

Journal Articles

Sensitive detection of human cytomegalovirus peptide–specific cytotoxic T-lymphocyte responses by interferon-γ–enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation

Holger Hebart, Senay Daginik, Stefan Stevanovic, Ulrich Grigoleit, Andrea Dobler, Manuela Baur, Georg Rauser, Christian Sinzger, Gerhard Jahn, Juergen Loeffler, Lothar Kanz, Hans-Georg Rammensee, Hermann Einsele

Blood (2002) 99 (10): 3830–3837.

https://doi.org/10.1182/blood.V99.10.3830

Published: 2002

Journal Articles

Risk for cytomegalovirus disease in patients receiving polymerase chain reaction–based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality

Holger Hebart, Wolfram Brugger, Ulrich Grigoleit, Barbara Gscheidle, Juergen Loeffler, Hansjörg Schäfer, Lothar Kanz, Hermann Einsele, Christian Sinzger

Blood (2001) 97 (7): 2183–2185.

https://doi.org/10.1182/blood.V97.7.2183

Published: 2001

NARROW

Long-Term Follow-up of Patients with Corticosteroid-Refractory Graft-Versus-Host Disease Treated with Ruxolitinib

Peptide-Receptor Radiotherapy with CXCR4-Targeting Pentixather Reduces Leukemia Burden in Acute Leukemia PDX and Patients

Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients

Allogeneic SCT in Multiple Myeloma: Limited Predictive Value of Chimerism Analysis for Heralding Relapse/Progression Due to Extramedullary Disease

High-density preculture of PBMCs restores defective sensitivity of circulating CD8 T cells to virus- and tumor-derived antigens

Wilms Tumor Protein-1-Derived 9-Mer Peptide Induces CD4 T-Cell Responses in an HLA-DR Restricted Manner

Salvage Therapy with Everolimus Reduces the Severity of Treatment-Refractory Chronic Graft-Versus-Host Disease without Impairing Disease Control: A Dual Center Experience

Simultaneous Isolation and Enrichment of Multi Specific and Multi Functional T-Cells Populations for Treatment of Patients Undergoing Allogeneic Hematopoetic Stem Cell Transplantation,

Monocyte-Derived Dendritic Cells Pulsed with Aspergillus Fumigatus Components Enhance the Anti-Aspergillus Effect of Human Natural Killer Cells

Modified Vaccinia Ankara Virus (MVA) Induces a Th1-Polarized Immune Response in Antigen-Presenting Cells (APCs).

Combined Phosphoepitope Specific Flow Cytometry and MHC-Multimer Staining - A New Tool to Monitor Antigen-Specific Signaling in CMV-Specific T-Cells.

Evaluation of Different Co-Stimulatory Signals in the Priming and Expansion of HLA-B*0702/CMV_pp65 Restricted CTLs after Stimulation with aAPC

CTL Responses Against Tumor Associated Antigens Are Part of the Graft Versus Leukemia-Effect and Protect from Relapse after Allogeneic Hematopoetic Stem Cell Transplantation.

Streptamer Technology for the Assessment of CMVpp65 Specific CD8+ T Cell Frequencies and for the Adoptive T Cell Transfer to Post-Transplant Patients.

Dendritic Cell Vaccination Induces HCMV Specific T-Cell Responses in Allogeneic Stem Cell Recipients.

Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

Sensitive detection of human cytomegalovirus peptide–specific cytotoxic T-lymphocyte responses by interferon-γ–enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation

Risk for cytomegalovirus disease in patients receiving polymerase chain reaction–based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only